MRK - Merck & Co Inc
Close
118.45
0.990 0.836%
Share volume: 8,874,162
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$117.46
0.99
0.84%
Fundamental analysis
48%
Profitability
23%
Dept financing
27%
Liquidity
65%
Performance
73%
Performance
5 Days
1.59%
1 Month
2.78%
3 Months
-4.31%
6 Months
-6.46%
1 Year
10.34%
2 Year
43.98%
Key data
Stock price
$118.45
DAY RANGE
$117.15 - $118.75
52 WEEK RANGE
$97.23 - $134.63
52 WEEK CHANGE
$0.11
DIVIDEND
$0.77
EX-DIVIDEND DATE
06/17/2024
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO:
Region: US
Website: https://www.merck.com/
Employees: 67,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.merck.com/
Employees: 67,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.
Recent news